MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    The P3a wave and cognitive decline in relation to Parkinson’s disease severity

    G. Sánchez Dinorín, M. Rodríguez Violante, A. Cervantes Arriaga, C. Navarro Roa, R. Solís Vivanco (Mexico City, Mexico)

    Objective: To explore the association between the P3a wave, cognitive decline, and severity of Parkinson’s disease (PD). Background: It has been proposed that cognitive changes…
  • 2019 International Congress

    Functional connectivity and microstructural alterations in regions of synaptic density loss in DLB and PDD

    T. Yousaf, G. Dervenoulas, G. Pagano, C. Loane, H. Wilson, A. Chandra, O. Cousins, R. Gunn, E. Rabiner, F. Niccolini, M. Esposito, L. Ricciardi, D. Aarsland, M. Politis (London, United Kingdom)

    Objective: We aimed to investigate whether functional connectivity and white matter integrity is altered in regions exhibiting reduced synaptic density, as measured by [11C]UCB-J-PET,in Dementia with…
  • 2019 International Congress

    Extracellular α-synuclein enters dopaminergic neurons by modulating flotillin-1-assisted DAT endocytosis

    T. Hasegawa, J. Kobayashi, N. Sugeno, S. Yoshida, T. Akiyama, Y. Miki, M. Fukuda, M. Ezura, A. Kikuchi, T. Baba, A. Takeda, K. Wakabayashi, H. Okano, M. Aoki (Sendai, Japan)

    Objective: In this study, we examine the regulatory role of flotillin-1 in dopamine transporter (DAT) trafficking and the impact of extracellular α-synuclein (αS) on this…
  • 2019 International Congress

    Blood Metagenomics Analyses of Brazilian Parkinson’s Disease Patients: A Clinical Substype Study

    G. Poralla, V. Rayol, N. Woldmar, B. Fadel, L. Giacomin, A. Rosso, L. Pizzatti (Rio de Janeiro, Brazil)

    Objective: The goal of this study is to analyze the dormant microbiome present in blood of Parkinson’s disease (PD) patient and healthy controls samples by…
  • 2019 International Congress

    Self-reported demographic, genetic, symptom, and treatment data of subjects in the Fox Trial Finder

    M. Bailey, A. Gera, Y. Liu, B. Ouyang, G. Pal (Chicago, IL, USA)

    Objective: To examine the characteristics of subjects within the Fox Trial Finder (FTF) database. Background: FTF is an online, patient driven database by which Parkinson’s…
  • 2019 International Congress

    Movement Disorders Spectrum in a Private Practice setup in India : A 7 Year Study

    P. Kukkle (Bangalore, India)

    Objective: To study the pattern and spectrum of Movement Disorders patients seen at a Private Movement Disorders Clinic in India Background: There is lack of…
  • 2019 International Congress

    Parkinsonism in a movement disorder reference center in El Salvador

    D. Pereira (San Salvador, El Salvador)

    Objective: To describe the frequency of Parkinson's disease and parkinsonism in a movement disorder reference center in El Salvador. Background: El Salvador is a  country…
  • 2019 International Congress

    Association of metallic air pollution with Parkinson’s disease: a French nationwide incidence study

    T. Vlaar, E. Lequy-Flahault, E. Moutengou, C. Meyer, S. Leblond, A. Elbaz, F. Moisan (Villejuif, France)

    Objective: To determine whether atmospheric deposition of 6 metal trace elements - copper (Cu), iron (Fe), manganese (Mn), mercury (Hg), lead (Pb), and zinc (Zn)…
  • 2019 International Congress

    Comparison between [11C]PE2I PET and [123I]FP-CIT SPECT as markers of DAT expression in early Parkinson’s disease

    T. Yousaf, G. Pagano, H. Wilson, B. Corcoran, G. Vivian, M. Politis (London, United Kingdom)

    Objective: To compare single-photon emission computed tomography (SPECT) with [123I]FP-CIT and positron emission tomography (PET) with [11C]PE2I as markers of dopamine transporter (DAT) loss in…
  • 2019 International Congress

    Long-term effects of bilateral subthalamic nucleus stimulation on sleep in patients with Parkinson’s disease

    J. Choi, H. Kim, D. Yoo, J. Im, S. Paek, B. Jeon (Seoul, Republic of Korea)

    Objective: The objective of this study was to assess long-term effects of deep brain stimulation (DBS) of the subthalamic nucleus (STN) on sleep in patients…
  • « Previous Page
  • 1
  • …
  • 105
  • 106
  • 107
  • 108
  • 109
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley